Elicio Therapeutics (ELTX) Retained Earnings (2020 - 2026)
Elicio Therapeutics (ELTX) reported Retained Earnings of -$245.5 million for Q1 2026, down 19.58% on a YoY basis from -$305.3 million in Q1 2025, and down 5.06% quarter-over-quarter from -$233.7 million in Q4 2025.
Elicio Therapeutics (ELTX) Retained Earnings (2020 - 2026) Analysis & Trends
Elicio Therapeutics has reported Retained Earnings for 7 years, with the latest figure at -$245.5 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 19.58% year-over-year to -$245.5 million; the trailing twelve-month figure through Mar 2026 stood at -$245.5 million (down 19.58% YoY), and the FY2025 full-year result was -$233.7 million, down 133426.86% from the prior year.
- Retained Earnings for Q1 2026 stood at -$245.5 million, down from -$233.7 million in the prior quarter.
- The five-year high for Retained Earnings was $302000.0 in Q3 2022, with the low at -$258.5 million in Q1 2023.
- Historically, Retained Earnings has averaged -$130.4 million across 5 years, with a median of -$133.3 million in 2023.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 100.13% — and 2025, when it tumbled 133426.86%.
- Elicio Therapeutics' Retained Earnings stood at -$107.0 million in 2022, then surged by 99.82% to -$197000.0 in 2023, then advanced by 11.17% to -$175000.0 in 2024, then plunged by 133426.86% to -$233.7 million in 2025, then declined by 5.06% to -$245.5 million in 2026.
- The last three Retained Earnings figures came in at -$245.5 million (Q1 2026), -$233.7 million (Q4 2025), and -$226.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | -245.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -245.50 Mn |
| Dec 31, 2025 | -233.67 Mn |
| Sep 30, 2025 | -226.00 Mn |
| Jun 30, 2025 | -215.87 Mn |
| Mar 31, 2025 | -205.31 Mn |
| Dec 31, 2024 | -175,000.00 |
| Sep 30, 2024 | -202,000.00 |
| Jun 30, 2024 | -238,000.00 |
| Mar 31, 2024 | -270,000.00 |
| Dec 31, 2023 | -197,000.00 |
| Sep 30, 2023 | -133.30 Mn |
| Jun 30, 2023 | -122.60 Mn |
| Mar 31, 2023 | -258.48 Mn |
| Dec 31, 2022 | -107.01 Mn |
| Sep 30, 2022 | 302,000.00 |
| Jun 30, 2022 | -238.50 Mn |
| Mar 31, 2022 | -229.40 Mn |
| Dec 31, 2021 | -103,000.00 |
| Sep 30, 2021 | -230.03 Mn |
| Jun 30, 2021 | -214.30 Mn |